CorMedix Inc.
General ticker "CRMD" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $728.3M (TTM average)
CorMedix Inc. follows the US Stock Market performance with the rate: 28.7%.
Estimated limits based on current volatility of 2.1%: low 9.97$, high 10.41$
Factors to consider:
- Total employees count: 83 (+102.4%) as of 2023
- Top business risk factors: Operating losses and capital needs, Regulatory and compliance, Dependence on key management, Strategic risks and growth management, Operational and conduct risks
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.12$, 16.47$]
- 2025-12-31 to 2026-12-31 estimated range: [6.10$, 14.16$]
Financial Metrics affecting the CRMD estimates:
- Negative: with PPE of -25.3 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -10.29 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 4.31 > -0.66
- Positive: Shareholder equity ratio, % of 71.23 > 63.39
- Positive: Interest expense per share per price, % of 0.01 <= 0.01
Short-term CRMD quotes
Long-term CRMD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.07MM | $0.00MM | $43.47MM |
| Operating Expenses | $30.69MM | $48.96MM | $65.83MM |
| Operating Income | $-30.62MM | $-48.96MM | $-22.36MM |
| Non-Operating Income | $0.34MM | $2.62MM | $3.03MM |
| Interest Expense | $0.03MM | $0.03MM | $0.04MM |
| R&D Expense | $10.68MM | $13.16MM | $3.94MM |
| Income(Loss) | $-30.29MM | $-46.34MM | $-19.32MM |
| Taxes | $-0.59MM | $0.00MM | $-1.39MM |
| Profit(Loss)* | $-29.70MM | $-46.34MM | $-17.93MM |
| Stockholders Equity | $55.06MM | $70.14MM | $84.66MM |
| Inventory | $0.00MM | $2.11MM | $7.60MM |
| Assets | $62.04MM | $82.06MM | $118.85MM |
| Operating Cash Flow | $-24.36MM | $-38.41MM | $-50.61MM |
| Capital expenditure | $0.22MM | $0.33MM | $0.12MM |
| Investing Cash Flow | $-3.71MM | $-17.06MM | $21.23MM |
| Financing Cash Flow | $17.90MM | $55.92MM | $26.32MM |
| Earnings Per Share** | $-0.74 | $-0.91 | $-0.30 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.